Home
Storia in 1 fonti
Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
Raccontata da
morningstar.com
Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
